![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Launch of THELIN in United Kingdom
06 nov. 2006 03h30 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 6, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium)(2) 100 mg tablets in the United Kingdom for...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Submits Complete Response to FDA For Thelin New Drug Application
02 nov. 2006 16h40 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced that following discussions today with the U.S. Food and Drug Administration (FDA), the Company has submitted a...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Reports Third Quarter 2006 Financial Results
02 nov. 2006 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2006.
Third Quarter Financial Overview
...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Secures Equity Financing Commitment
19 oct. 2006 18h45 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 19, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has secured a commitment for up to $75 million in a common stock equity financing from Azimuth...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2006 Results
16 oct. 2006 16h45 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 16, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Thursday, November 2, 2006 at 8:00 a.m. ET to discuss its third quarter 2006...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
THELIN (Sitaxentan Sodium) Receives European Marketing Authorization for Treatment of Pulmonary Arterial Hypertension
11 août 2006 13h16 HE
|
Encysive Pharmaceuticals Inc.
European Commission Grants First Selective, Once Daily Oral Endothelin A
Receptor Antagonist Approval in All 25 European Union Member States
Conference Call Scheduled for Monday, August...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Receives Notification of Marketing Authorization From European Commission Regarding THELIN (Sitaxentan Sodium)
10 août 2006 15h18 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 10, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) was notified today that the European Commission has adopted the decision granting marketing authorization for THELIN(r)(1)...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Reports Second Quarter 2006 Financial Results
07 août 2006 07h02 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 7, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the second quarter ended June 30, 2006.
Second Quarter Financial Overview
--...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2006 Results
27 juil. 2006 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 27, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Monday, August 7, 2006 at 8:00 a.m. ET to discuss its second quarter 2006...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Reports First Quarter 2005 Financial Results
28 avr. 2005 16h01 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, April 28, 2005 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the first quarter ending March 31, 2005.
"In the first quarter, we saw the...